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Background ‘Kangaroo mother care’ (KMC) includes thermal care through con-
tinuous skin-to-skin contact, support for exclusive breastfeeding or
other appropriate feeding, and early recognition/response to illness.
Whilst increasingly accepted in both high- and low-income coun-
tries, a Cochrane review (2003) did not find evidence of KMC’s
mortality benefit, and did not report neonatal-specific data.
Objectives The objectives of this study were to review the evidence, and esti-
mate the effect of KMC on neonatal mortality due to complications
of preterm birth.
Methods We conducted systematic reviews. Standardized abstraction tables
were used and study quality assessed by adapted GRADE method-
ology. Meta-analyses were undertaken.
Results We identified 15 studies reporting mortality and/or morbidity
outcomes including nine randomized controlled trials (RCTs) and
six observational studies all from low- or middle-income settings.
Except one, all were hospital-based and included only babies of
birth-weight <2000 g (assumed preterm). The one community-
based trial had missing birthweight data, as well as other limita-
tions and was excluded. Neonatal-specific data were supplied by
two authors. Meta-analysis of three RCTs commencing KMC in
the first week of life showed a significant reduction in neonatal
mortality [relative risk (RR) 0.49, 95% confidence interval (CI)
0.29–0.82] compared with standard care. A meta-analysis of three
observational studies also suggested significant mortality benefit
(RR 0.68, 95% CI 0.58–0.79). Five RCTs suggested significant reduc-
tions in serious morbidity for babies <2000 g (RR 0.34, 95% CI
0.17–0.65).
Conclusion This is the first published meta-analysis showing that KMC
substantially reduces neonatal mortality amongst preterm babies
(birth weight <2000 g) in hospital, and is highly effective in redu-
cing severe morbidity, particularly from infection. However, KMC
remains unavailable at-scale in most low-income countries.
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Background
Preterm birth (<37 completed weeks of gestation) is
the largest direct cause of neonatal mortality,
accounting for an estimated 27% of the 4 million
neonatal deaths every year1 and is also the most
important risk factor for neonatal deaths for example
from infection.2 In high-income countries where tet-
anus, neonatal infections and intrapartum-related
neonatal deaths are rare, preterm birth is the
dominant cause of neonatal mortality and morbidity
and a major contributor to long term impairment. In
low-income countries, whilst deaths directly due to
preterm birth are a smaller proportion of deaths, the
cause-specific mortality rate is 6-fold greater than in
high-income countries. For example, the preterm
cause-specific neonatal mortality rate in Europe is
1.5 per 1000 births, compared with almost 10 per
1000 births in Africa.2 This is a reflection of the lack
of even basic care.1 Each year 60 million babies are
born outside facilities and even among those born
in facilities in low-income countries, few babies who
need it receive basic care let alone intensive care with
ventilator support.3 Most published trials of neonatal
care focus on incremental gains with high-technology
care—for example changes in ventilation methods—
and have been of limited relevance to the settings
with 99% of neonatal deaths.1
The burden on health systems imposed by care of
preterm infants in high-income countries is consider-
able and well recognized. Indeed it is estimated that
the cost of care for a single preterm birth in the USA
is US$ 51 600.4 This challenge still largely remains
invisible in low-income countries but is actually of
greater magnitude as preterm birth rates are higher
and the resources available fewer, characterized by
understaffed hospitals with ill equipped or non-exis-
tent neonatal care units which ultimately result in
higher neonatal mortality rates.5
In the early 1970s, motivated by problems arising
from shortage of incubators and also the impact of
mother and newborn separation, Colombian paedia-
trician Edgar Rey developed a technologically simple
method later named ‘Kangaroo mother care’ (KMC).6
KMC has three main components including thermal
care through continuous skin-to-skin contact by being
tied with a cloth to the front usually of the mother;
support for exclusive breastfeeding or other appropri-
ate feeding; and early recognition and response to
complications.7 In addition, it is postulated that the
baby is colonized by the mother’s commensual organ-
isms reducing the risk of nosocomial infection
especially in a hospital environment. KMC can be
started after birth as soon as the baby is clinically
stable, and can be continued at home until the baby
is stronger and begins to wriggle out which is often
around the time the baby would have been born if
they had been full term.
Acceptance of the KMC method is increasingly
widespread and it is considered equivalent to conven-
tional neonatal care for stable preterm infants and
more parent and baby friendly.8,9 World Health
Organization (WHO) guidelines have been pub-
lished.10 Uptake of KMC in high-income country neo-
natal units has been highlighted as a rare example
of south-to-north transfer of health interventions.5
However, the most recent Cochrane review of KMC
(last updated in 2003) reported no evidence of a mor-
tality effect.11 The lack of convincing mortality benefit
has been an impediment to uptake.
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Objective
This review aims to assess the effect on neonatal mor-
tality from complications of preterm birth of KMC
compared to no care at all or compared to conven-
tional care. A neonatal death in a baby with a birth
weight of <2000 g (32–34 weeks gestation) is most
commonly due to complications of prematurity and
hence we assume that deaths in this birth weight
category can be considered to be cause-specific for
direct complications of preterm deaths.
Methods
Searches
Systematic searches were undertaken of electronic
databases including Cochrane Libraries, PubMed,
LILACS, African Medicus, EMRO and all World
Health Organization Regional Databases and included
publications in any language (Figure 1). Online
searches of major conference proceedings were also
conducted in order to identify unpublished literature.
The key search terms included were: ‘Kangaroo Mother
Care’, ‘Kangaroo Care’ and ‘Skin to skin care.’ The system-
atic searches were for studies published between 1968
and 8 September 2009. After initial screening of titles
and abstracts we reviewed full-text publications of
possible studies.
Inclusion/exclusion criteria, abstraction
We applied the PICO format (Patient, Intervention,
Comparison and Outcome) to define the studies to
be included as follows. The population of interest
were neonates, and the intervention being studied was
KMC as defined above (continuous skin-to-skin con-
tact; support for exclusive breastfeeding or other
appropriate feeding; and early recognition and
response to complications). KMC is commenced
once the neonatal is stable irrespective of age, but
in some of the early trials KMC was only commenced
after the first week of life. Since 75% of neonatal
deaths occur in the first week1 these criteria would
introduce substantial survival bias and not be compa-
rable with studies examining early initiation of KMC.
We therefore excluded trials which only commenced
KMC after the first week of life. The comparison pop-
ulation is conventional care which depending on the
study setting may be incubator care or more limited
care. We sought to identify randomized controlled
trials but given the lack of such studies especially in
low income settings we also reviewed observational
studies fitting the above criteria.
The outcomes of interest were (i) neonatal mortality
due to complications of preterm birth as used in
International Classification of Disease version 10 and
for global estimates for neonatal mortality; and
(ii) serious neonatal morbidity related to prematurity
(respiratory distress syndrome, pneumonia, septicae-
mia). Neonatal refers to the first 28 days of life.
Figure 1 Synthesis of study identification in review of the effects of KMC on neonatal morbidity and mortality in preterm
labour. Bold boxes signifies new meta-analysis undertaken (searches from 1970 to 9 September 2009)
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Where studies only reported mortality for another
time period (e.g. infant) we wrote to principal inves-
tigators to request the neonatal–specific data. Given
that most studies do not report cause specific mortal-
ity, or even gestation-specific mortality, a birthweight
limit had to be defined as a surrogate. Based on birth
weight and gestational age charts and on dataset with
cause-specific mortality data by weight and gesta-
tional age, a birth weight of 42000 g has previously
been defined by WHO as an acceptable equivalent for
preterm birth likely to be the major underlying cause
of death.2 Studies of KMC which reported only weight
gain, breastfeeding status or psycho-social outcomes
were not analysed here.
All studies meeting the inclusion criteria were
double data abstracted into a standardized form. We
abstracted key variables with regard to the study
identifiers and context, study design and limitations,
intervention specifics, and outcome effects. We
assessed the quality of each of these studies using a
standard approach developed by the Child Health
Epidemiology Reference Group (CHERG) based on
an adaptation of the GRADE approach.12 For studies
which reported mortality outcomes that were not neo-
natal specific, we contacted the authors to request the
neonatal specific data.
Analyses, and summary measures
We planned a priori to conduct three meta-analyses,
two for mortality outcomes (one with randomized
controlled trials (RCTs) as inputs and one with obser-
vational studies), and one for morbidity outcomes
(RCTs only). We also planned to undertake additional
sensitivity analysis to examine bias that may be intro-
duced by excluding certain studies not meeting our
inclusion criteria. We conducted all meta-analysis
using STATA version 10.0 statistical software13 and
report the Mantel–Haenszel pooled relative risk (RR)
and corresponding 95% confidence interval (CI).
Heterogeneity between studies was summarized
using the I2 statistic. If this statistic exceeded 10%
then a random effects analysis was performed as
opposed to fixed effects. We summarized the overall
quality of evidence for each outcome and each data
input type using an adapted version of the GRADE
protocol table.12
Results
Our searches identified 6127 titles (Figure 1).
After initial screening of titles and abstracts we
reviewed 524 papers for the outcomes of interest,
including several in French, Spanish and Portuguese.
We identified 15 studies of which nine studies8,14–21
were either individually randomized (eight) or cluster
randomized trials (one),14 six were observational
studies.22–27 All the studies were from low or
middle-income countries—Colombia, Ethiopia,
Ecuador, Ethiopia, Indonesia, Bangladesh, India,
Mexico and South Africa. None of the studies were
blinded, as this was not possible for KMC. Some
of the studies only tracked pre-discharge mortality,
but given the average length of stay of several
weeks and the fact that most deaths are in the first
few days of life, this is unlikely to result in major
bias. The details of each study and quality assessment
using GRADE are summarized in Supplementary
Table 1.
In all but one of the studies, the intervention was
only offered to babies with birth weight <2000 g who
were hospital inpatients. In one trial KMC was com-
menced at home and included babies of all birth
weights but there was no mortality benefit detected
for babies 42000 g.14 Our inclusion criteria was for
only babies <2000 g as an indication of the effect
on preterm specific mortality. The only trial including
babies with a birth weight42000 g did find evidence
of a mortality effect for such babies. Only two studies
included specified a lower weight limit for exclusion
of babies for KMC, set at 1000 g.18,27 For all but
two studies the KMC was reported to be continuous
(i.e. 24-h skin-to-skin contact). In two trials the
investigators report that the practice may not have
been continuous.14,15
RCTs
We identified nine RCTs, of which six had mortality
outcomes (Figure 1, Table 1).8,14–18 In two of the early
studies.17,18 KMC was started after babies were one
week old or older. Based on our exclusion criteria
described above, given the substantial risk of bias,
these were excluded from both mortality and morbid-
ity analysis. Concerning the grade quality assessment
of RCT trials, Table 1 shows that there were minor
limitations in most studies, such as the assessment
not being blinded, although by its nature KMC
as an intervention cannot be blinded. All but one
study specified that data were analysed by intention
to treat.14 More details of the potential sources of bias
in each trail are given in Supplementary Table 1.
The Bangladesh community trial14 had important
limitations and was therefore excluded from our
primary analyses. The main trial results apply to all
babies, not just those <2000 g. However, not all
babies in the intervention arm received KMC, and
those who did may not have received 24-h KMC.14
Furthermore data on birth weight was missing for
the majority of babies (65%) and so the reported
estimate of effect in babies below 2000 g is based on
‘modelled data’.14
Mortality Outcome in RCTs
Among the six RCTs with mortality data, two studies
in which the intervention was initiated after 7 days
post-delivery were excluded.17,18,21 Two studies8,15
reported mortality at 12 and 9 months, respectively.
We wrote to principal investigators of studies that did
not report data for the neonatal period to obtain this
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information.8,15 The Bangladesh community-based
KMC trial14 was excluded as discussed above.
Three studies, all from low/middle-income countries,
were thus included in the final meta-analysis8,15,16
(Figure 2a). Only Charpak’s study was in the previous
Cochrane mortality meta-analysis but in that analysis
the neonatal specific mortality data were not
available. The studies were all of moderate or high
quality. In our meta-analysis, KMC was associated
with a major reduction in neonatal death for babies
<2000 g (RR 0.49, 95% CI 0.29–0.82, I2¼ 0, 3 studies,
988 infants) (Figure 2a).
We undertook a sensitivity analysis to examine the
effect on neonatal mortality of including the two
trials with late initiation of KMC.17,18 As expected
the estimated risk ratio was closer to 1 (RR 0.64;
95% CI.0.42–0.96), although still a significant mortal-
ity effect (plot not shown).
A second sensitivity analysis was undertaken by
including the Bangladesh community KMC study14
either with all the babies, or restricted to those
<2000 g (modelled data). We estimated a design
effect (1.24) from the CIs presented by the authors
unadjusted and adjusted for the design effect.14 If
restricted to just the babies <2000 g, this had no
effect on the point estimate with (RR 0.49; 95% CI
0.32–0.76). If all the babies in the study irrespective
of birth weight are included in the meta-analysis
there is evidence of heterogeneity (I2¼ 55%,
P¼ 0.08). Using a random effects meta-analysis
where as the RR is 0.68, the CI is wide (0.38, 1.22),
with no significant evidence of a mortality benefit.
Morbidity Outcome in RCTs
Morbidity was defined as severe infection such as
sepsis, necrotizing enterocolitis and severe pneumonia
although some authors did not give very clear defini-
tions. A total of five studies met the inclusion criteria
and were included in the meta-analysis, all studies
were of moderate or high quality. All five studies
reported reductions in severe morbidity although
there is evidence of heterogeneity across trials
(I2¼ 70%, P¼ 0.01). KMC was associated with a reduc-
tion in serious neonatal morbidity (RR¼ 0.34, 95% CI
0.17–0.65, five studies, 1520 babies) (Figure 2b).
Observational studies
We conducted a further analysis of mortality using
three observational studies which had a relevant com-
parison group (Table 2).23,25,27 One study8 was
excluded since KMC was started when babies were
1 week old.22 The meta-analysis showed a reduction
in neonatal mortality in babies <2000 g, which was
slightly smaller than that observed in the randomized
trials (RR 0.68, 95% CI 0.58–0.79, three studies, 8257
infants) (Figure 3). This result was largely driven by a
large South African evaluation even though we
restricted the inputs sites with comparable before
and after audit data (8151 babies).27 The interventionT
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was variably implemented in the different institutions
and data collection was through routine mortality
audit. Two of the other studies had weight limits
<2000 g to commence KMC (160023 and 1800,25
respectively) but these contributed very small num-
bers of babies compared to the South African study.
The Mozambique and Zimbabwean studies reported
implementation problems such as non-acceptance by
mothers of ‘abnormal’ or ill babies and increased
workload on staff.23,25 Effect size was smaller in
both these studies, and non significant in the
Zimbabwean study.23
Overall  (I-squared = 0.0%, p = 0.539)
Suman,2008
Charpak, 1997
Study
Worku,2008
0.49 (0.29, 0.82)
0.18 (0.02, 1.56)
0.38 (0.07, 1.94)
RR (95% CI)
0.57 (0.33, 1.00)
100.00
13.73
15.10
%
Weight
71.17
.1 .5 1 2
NOTE: Weights are from random effects analysis
Overall  (I-squared = 69.7%, p = 0.010)
Sloan, 1994
Charpak, 1997
Study
Suman, 2008
Cattaneo, 1998
Udani, 2007
0.34 (0.17, 0.65)
0.30 (0.13, 0.66)
0.70 (0.44, 1.11)
ES (95% CI)
0.19 (0.07, 0.55)
0.51 (0.28, 0.94)
0.04 (0.01, 0.27)
100.00
21.71
27.53
%
Weight
17.47
25.01
8.29
.1 .5 1 2
(a)
(b)
Figure 2 (a) Meta-analysis of three RCTs comparing KMC with standard care showing cause-specific mortality effect for
babies of birth weight <2000 g (assumed to be deaths due to direct complications of preterm birth) and excluding studies
where KMC was started after the first week of life. (b) A meta-analysis of five RCTs comparing KMC with standard care
showing effect on severe morbidity (severe pneumonia, sepsis, jaundice and other severe illness) for babies of birthweight
<2000 g and excluding studies where KMC was started after the first week of life. Unpublished neonatal specific data
courtesy of authors, Charpak and Suman
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Discussion
This is the first meta-analysis presenting evidence of
the mortality benefit of KMC. We report a large
cause-specific decrease of 51% (95% CI 18–71% reduc-
tion) in neonatal deaths with birth weight of <2000 g
based on three RCTs (988 babies). A meta-analysis of
three observational studies estimated a somewhat
smaller effect (32% reduction), although these data
are of lower quality and were in usual health
system implementation settings. It is evident that
KMC has a substantial mortality effect compared
with conventional neonatal care, and it is also evident
that this mortality benefit is possible even at large
scale.27
Our analysis underestimates the overall health ben-
efits as we did not include non-fatal outcomes or
effects beyond the neonatal period. The Cochrane
review for KMC assessed other outcomes in addition
to mortality and morbidity including weight gain,
breastfeeding and psycho-social outcomes such as
bonding and maternal satisfaction and length of hos-
pital stay. We have not reported on these here given
our purpose of estimating mortality effects, but it is
clear that there are other positive outcomes for the
baby, mother and also the health system in terms of
reduced work load for nurses and early discharge
from hospital care.
This mortality estimate has a high evidence grade
with the three RCTs from low and middle-income
countries showing extremely consistent results, with
only a slight reduction in quality as assessment was
not blinded (Table 3). The meta-analysis of observa-
tional trials provides supportive evidence of a substan-
tial mortality reduction, although largely driven by
one large study using before and after audit data.
We undertook two sensitivity analyses examining
the exclusions made but still only applied for babies
<2000 g. In both analysis significant evidence of large
mortality effects remained (RR 0.60 and 0.62).
However if all the normal birthweight babies in the
Bangladesh community-based study were included,
the uncertainty bounds were so wide that the result
was no longer significant.
There were several aspects of the studies we exam-
ined which mean that the mortality effect we have
obtained may be an ‘underestimation’ of the benefit
possible in many low-income settings (Box 1). First,
the control group in most studies was routine incu-
bator care whereas currently for most of the more
than one million neonatal deaths from preterm birth
complications, there is often no medical care at all.
Secondly, in the earlier trials there was a tendency
towards later initiation of KMC with strict restrictions
regarding age, weight or clinical status of babies. The
practice now is to start KMC earlier as soon as the
baby is clinically stable and this should result in a
higher impact since the majority of neonatal deaths
especially for small babies occur in the first few days
of life. Finally, some of the studies only trackedT
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pre-discharge mortality and did not cover the whole
neonatal period, giving rise to the possibility of an
under-estimation of post-discharge neonatal deaths.
However there are also important potential biases
that may result in an ‘overestimation’ of effect size,
notably the selection basis for starting KMC in
that only clinically stable preterm infants qualify
to start KMC hence this effect size may not be reflect
the reduction possible for all preterm deaths. Only
one study specified a lower birth weight limit for
starting KMC (1000 g).27 It may be that in settings
with no medical care at all for the smallest babies,
KMC may be better than nothing—this requires fur-
ther evaluation.
Where as this review establishes a clear and major
impact on neonatal mortality, many questions remain
around how to implement. Despite the high impact
and apparent feasibility of KMC, few preterm babies
in low-income countries currently have access to this
intervention. No systematic data on global coverage
are available. It appears that, in addition to
Colombia, a number of countries in Latin America
have made progress in scaling up KMC.17,18 In Asia
there are many units now in Indonesia and some in
India and Bangladesh but population coverage
remains very low in these large countries. Within
Africa, South Africa has multiple sites in almost
every province27,28 and has employed a low cost
model for lower levels in the health system which
does not require special units. Malawi has a number
of units but all at referral level.29 In most other
African countries there are few if any units and
these are mainly in capital cities and their presence
has depended heavily on local champions to overcome
initial resistance. A few countries notably Malawi,29
Tanzania and Ghana now have plans in place to scale
up KMC to district hospital or even health centre
level. To inform this process it is crucial to understand
the constraints to scale up. These constraints may be
due to lack of information about effectiveness, or is
there reluctance to change current practice even if
there are multiple babies per incubator, or perhaps a
lack of trust in mothers and letting them onto neo-
natal units? Is KMC seen as a ‘poor country only’
solution? Formative work around these constraints
as well as analyses of cost and potential cost savings
on nursing time and length of in-patient stay are
needed.
A priority research question concerns community
KMC. There is only one study examining KMC initi-
ation at home, in a challenging setting in rural
Bangladesh.14 This study demonstrated a substantial
mortality benefit for babies <2000 g (or modelled
birth weight based on adjusted first weight after
birth) but not for normal birthweight babies. At this
stage, community initiation of KMC cannot be recom-
mended based on the evidence from this one trial and
larger trials in different settings are required. There
are ethical concerns regarding increasing care for
small babies at home without effective referral care
as more babies will be identified who cannot be man-
aged at home. It is important that KMC is not con-
fused with routine skin-to-skin care alone, which is
recommended at birth for all babies, whether in facil-
ity or at home, although the definitions for this prac-
tice and mortality effect data are lacking.
In addition there are no studies in low-income
countries of KMC initiation at facility level with
Overall  (I-squared = 54.4%, p = 0.112)
Pattinson, 2006
Kambarimi, 1997
Study
Lincetto, 2000
0.68 (0.58, 0.79)
0.69 (0.59, 0.81)
0.14 (0.01, 2.67)
RR (95% CI)
0.34 (0.16, 0.72)
100.00
96.06
0.95
Weight
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.1 .5 1 2
Figure 3 A meta-analysis of three observational trials comparing KMC with standard incubator care showing cause specific
mortality effect for babies of birthweight <2000 g (assumed to be deaths due to direct complications of preterm birth).
Pattinson data restricted to sites with comparable before/after data27
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effective links to home after discharge. Given the
inpatient stay of weeks or even months for very pre-
term babies, early discharge with effective links to the
home would be of benefit to family and facility, but
how would this work in practice in weaker health
systems and is there a risk of increasing mortality
post-discharge?
Conclusion
Evidence has been analysed from a number of RCTs
and is consistent with a meta-analysis from
large-scale effectiveness evaluations. KMC has a
large effect on neonatal mortality and is also effective
in reducing morbidity. This evidence is sufficient to
recommend the routine use of KMC in facilities for all
stable babies <2000 g at birth. The potential effect of
KMC is expected to be greatest in low-income coun-
tries, where other options for care of preterm babies
remain limited with few neonatal care units, often inT
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Box 1 Cause specific mortality effect and quality grade
of the estimate for the effect of facility-based KMC
Cause specific mortality to act on:
Preterm direct complications (within neonatal
period)
Cause specific effect and range:
51% reduction (18–71%)
Quality of input evidence:
High (Three RCTS in low/middle-income coun-
tries), Mortality and morbidity data consistent
Observational data from large scale implementation
trials are consistent
Proximity of the data to cause specific mortal-
ity effect:
High (cause specific mortality)
Limitations of the evidence:
Several systematic biases resulting in underestima-
tion of mortality effect
(1) The control group in all these studies is rou-
tine incubator care, whereas the group of
interest for policy/programmes are babies cur-
rently receiving no medical care
(2) Late initiation of KMC/strict restriction to
older, stable babies, whereas practice now is
to start KMC earlier. Early initiation of KMC
for stable babies is likely to be higher impact
since up to 50% of neonatal deaths occur on
the first day of life
(3) Several studies track pre-discharge mortality
only so some underestimation of neonatal
mortality reduction
One important bias that may lead to over estima-
tion is survival bias—the sickest babies may die
before meeting criteria to commence KMC, or
may not meet criteria of being clinically stable.
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distant referral hospitals and understaffed and ill-
equipped. If KMC were to reach high coverage through
implementation at lower levels of the health system,
the world’s annual one million neonatal deaths due
to preterm birth could be substantially reduced.
Supplementary data
Supplementary data are available at IJE online.
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KEY MESSAGES
 KMC is a simple intervention to care for preterm newborns by tying the baby to the mothers front,
providing thermal care through continuous skin to skin contact, increased breastfeeding, reduced
infections and early recognition of illness.
 Previous reviews have not shown a significant mortality benefit, and included studies where the
intervention started after 1 week of age (survival bias) and have combined varying mortality out-
comes (predischarge, neonatal, 6 months and infant mortality). In addition several new studies have
been published.
 Our new meta-analysis of 3 RCTs shows major mortality reduction [51% (18–71%)] for neonatal
mortality in babies with birthweight <2000 g, with even greater reductions in serious morbidity.
 This evidence is sufficient to recommend the routine use of KMC for all babies <2000 g as soon as
they are stable. Up to half a million neonatal deaths due to preterm birth complications could be
prevented each year if this intervention were implemented at scale.
 Priority research gaps include studies of community level initiation of KMC as well as follow up of
facility KMC initiation with early discharge in low income countries.
References
1 Lawn JE, Cousens S, Zupan J. 4 million neonatal deaths:
when? Where? Why? Lancet 2005;365:891–900.
2 Lawn JE, Wilczynska-Ketende K, Cousens SN. Estimating
the causes of 4 million neonatal deaths in the year 2000.
Int J Epidemiol 2006;35:706–18.
3 Darmstadt GL, Bhutta ZA, Cousens S, Adam T, Walker N,
De Bernis L. Evidence-based, cost-effective interventions:
how many newborn babies can we save? Lancet 2005;365:
977–88.
4 Institute of Medicine. Preterm Birth. Causes, Consequences,
and Prevention. Washington, DC: National Academies
Press, 2007.
5 Ruiz-Pela´ez JG, Charpak N, Cuervo LG. Kangaroo Mother
Care, an example to follow from developing countries.
BMJ 2004;329:1179–81.
6 Rey E, Martinez H. Manejio racional del Nino Prematuro.
Bogota, Colombia: Universidad Nacional, Cursode
Medicina Fetal, 1983.
7 Charpak N, Riuz JG, Zupan J et al. Kangaroo mother care:
25 years after. Acta Paediatrica 2005;94:514–22.
8 Charpak N, Riuz-Pelaez JG, Figueroa Z, Charpak Y.
Kangaroo mother versus traditional care for newborn
infants less than or equal to 2000 grams: a randomised
controlled trial. Pediatrics 1997;100:682–89.
9 Charpak N, Riuz-Pelaez JG, Figueroa Z, Charpak Y. A
randomised controlled trial of Kangaroo mother care:
results of follow-up at one year of corrected age.
Pediatrics 2001;108:1072–79.
10 World Health Organisation. Kangaroo Mother Care: A
Practical Guide. Geneva: WHO, 2003.
11 Conde-Agudelo A, az-Rossello JL, Belizan JM. Kangaroo
mother care to reduce morbidity and mortality in low
birthweight infants. Cochrane Database Syst Rev 2003;2:
CD002771.
12 Schunemann HJ, Oxman AD, Brozek J et al. Grading
quality of evidence and strength of recommendations
for diagnostic tests and strategies. BMJ (Clinical research
ed) 2008;336:1106–10.
KANGAROO MOTHER CARE TO PREVENT NEONATAL DEATHS i153
13 STATA/IC 10.1. Statistical Program. College Station, TX:
STATA Corporation, 2008.
14 Sloan NL, Ahmed S, Mitra SN et al. Community-based
kangaroo mother care to prevent neonatal and infant
mortality: a randomized, controlled cluster trial.
Pediatrics 2008;121:e1047–59.
15 Suman RP, Udani R, Nanavati R. Kangaroo mother care
for low birthweight infants: a randomized controlled trial.
Indian Pediatr 2008;45:17–23.
16 Worku B, Kassie A. Kangaroo mother care: a randomized
controlled trial on effectiveness of early kangaroo mother
care for the low birthweight infants in Addis Ababa,
Ethiopia. J Trop Pediatr 2005;51:93–7.
17 Sloan NL, Camacho LW, Rojas EP, Stern C. Kangaroo
mother method: randomised controlled trial of an alter-
native method of care for stabilised low-birthweight
infants. Maternidad Isidro Ayora Study Team. Lancet
1994;344:782–85.
18 Cattaneo A, Davanzo R, Worku B et al. Kangaroo mother
care for low birthweight infants: a randomized controlled
trial in different settings. Acta Paediatrica 1998;87:976–85.
19 Udani. Innovation: KEM Kangaroo Bag - For Kangaroo
Mother Care. R. http://kangaroo.javeriana.edu.co/encuen-
tros/7encuentro/posters/Rekha%20Udani%204.pdf
(September 2009, date last accessed).
20 Ramanathan K, Paul VK, Deorari AK, Taneja U,
George G. Kangaroo Mother Care in very low birthweight
infants. Indian J Pediatr 2001;68:1019–23.
21 Roberts KL, Paynter C, McEwan B. A comparison of kan-
garoo mother care and conventional cuddling care.
Neonatal Netw 2000;19:31–35.
22 Charpak N, Ruiz Pelaez JG, Charpak Y. Rey-Martinez.
Kangaroo mother program: an alternative way of caring
for low birthweight infants? One year mortality in a two
cohort study. Pediatrics 1994;94:804–10.
23 Kambarami RA, Chidede O, Kowo DT. Kangaroo care
versus incubator care in the management of well
preterm infants. A pilot study. Ann Trop Paediatr 1998;
18:81–86.
24 Chwo MJ, Anderson GC, Good M, Dowling DA,
Shiau SH, Chu DM. A randomized controlled trial of
early kangaroo care for preterm infants: effects on tem-
perature, weight, behavior, and acuity. J Nurs Res 2002;10:
129–42.
25 Lincetto O, Nazir AI, Cattaneo A. Kangaroo
mother care with limited resources. J Trop Pediatr 2000;
46:293–95.
26 Rodrigues MAG, Cano MAT. Estudo do ganho de peso e
durac¸a˜o da internac¸a˜o do rece´m-nascido pre´-termo de
baixo peso com a utilizac¸a˜o do me´todo canguru. Revista
Eletroˆnica de Enfermagem 2006;8:185–91.
27 Pattinson RC, Bergh A-M, Malan AF, Prinsloo R. Does
kangaroo mother care save lives? J Trop Pediatr 2006;52:
438–41.
28 Bergh AM, Arsalo I, Malan AF, Patrick M,
Pattinson RC, Phillips N. Measuring implementation
progress in kangaroo mother care. Acta Paediatr 2005;
94:1102–8.
29 Bergh AM, van Rooyen E, Lawn J, Zimba E, Ligowe R,
Chiunda G. Retrospective Evaluation of KMC in Malawi.
Malawi Save the Children Country Office: MRC South
Africa and University of Pretoria, 2007.
i154 INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
